![](/img/cover-not-exists.png)
Effectiveness and safety of eribulin in Japanese patients with HER2-negative, advanced breast cancer: a 2-year post-marketing observational study in a real-world setting
Inoue, Kenichi, Takahashi, Masato, Mukai, Hirofumi, Yamanaka, Takashi, Egawa, Chiyomi, Sakata, Yukinori, Ikezawa, Hiroki, Matsuoka, Toshiyuki, Tsurutani, JunjiLanguage:
english
Journal:
Investigational New Drugs
DOI:
10.1007/s10637-019-00890-5
Date:
January, 2020
File:
PDF, 353 KB
english, 2020